Fig. 4From: Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncologyLigandtracer sensograms for a [111In]In-AU-SAR-M1, b [111In]In-AU-SAR-M2 and c [111In]In-AU-SAR-M3; association was measured at 1 nM and 3 nM radioligandBack to article page